Researchers identify bone-forming cells as the driver of scoliosis caused by a genetic disorder, which can be prevented ...

A high-level Indian delegation, led by Union Minister of Fisheries, Animal Husbandry and Dairying & Panchayati Raj, Rajiv Ranjan Singh, concluded a successful visit to Israel from January 13-15, 2026, ...

The UAE Ministry of Education has introduced an automatic degree recognition system for 34 universities, streamlining the ...

Data from Federauto on Italian registrations of industrial vehicles over 3.5 tonnes in 2025 show Iveco retaining the leading ...

Detailed price information for Bridgebio Oncology Therapeutics Inc (BBOT-Q) from The Globe and Mail including charting and trades.

In a world defined by rapid technological change, energy transition, and pressing sustainability demands, chemical ...

Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people.

Erasca reported favorable safety and tolerability with no dose-limiting toxicities and predominantly low-grade adverse events ...

BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on ...

At the beginning of January 2025, Grande Manila joined the Grimaldi fleet, becoming the seventh PCTC vessel with ...